AdvertisementGeneric Drugmakers Facing Antitrust Inquiry Over Rising PricesNovember 04, 2016Alison KodjakfacebookEmailGeneric drugmaker Mylan is one of the companies reported to be the subject of a Justice Department investigation into pricing of generic drugs. (Getty Images)